
    
      The study is open. However, the 4 different formulations of GSK's MenACWY conjugate vaccine
      will be administered in a double-blind manner. Mencevax™ ACWY vaccine will serve as active
      control. Subjects will receive one vaccine dose only (GSK's MenACWY conjugate vaccine or
      Mencevax™ ACWY vaccine), and will have 2 blood samples taken, before and one month after
      vaccination.
    
  